OPPTF
ALXN

OPSEU Pension Plan Trust Fund’s Alexion Pharmaceuticals ALXN Stock Holding History

OPSEU Pension Plan Trust Fund’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,775
Closed -$1.26M – 283
2021
Q2 		$1.26M Buy
+6,775
New +$1.16M 0.32% 137

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

OPSEU Pension Plan Trust Fund's ALXN Position: Q3 2021 in Review

OPSEU Pension Plan Trust Fund sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,775 shares — an estimated $1.26M sold.

OPSEU Pension Plan Trust Fund first reported a position in ALXN in Q2 2021 and held it in 1 quarter. The position peaked at $1.26M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • OPSEU Pension Plan Trust Fund reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • OPSEU Pension Plan Trust Fund sold 6,775 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.26M.
  • OPSEU Pension Plan Trust Fund first reported a position in Alexion Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • OPSEU Pension Plan Trust Fund's Alexion Pharmaceuticals position peaked at $1.26M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q3 2021, filed 12 Nov 2021.